Remarkable Solvent Effect on Pd(0)-Catalyzed Deprotection of Allyl Ethers Using Barbituric Acid Derivatives: Application to Selective and Successive Removal of Allyl, Methallyl, and Prenyl Ethers

Hirokazu Tsukamoto; Takamichi Suzuki; Yoshinori Kondo

doi:10.1055/s-2007-992352

LETTER

Remarkable Solvent Effect on Pd(0)-Catalyzed Deprotection of Allyl Ethers Using Barbituric Acid Derivatives: Application to Selective and Successive Removal of Allyl, Methallyl, and Prenyl Ethers

Hirokazu Tsukamoto*, Takamichi Suzuki, Yoshinori Kondo
Graduate School of Pharmaceutical Sciences, Tohoku University, Aramaki-aza aoba 6-3, Aoba-ku, Sendai 980-8578, Japan
Fax: +81(22)7953906; e-Mail: hirokazu@mail.pharm.tohoku.ac.jp;

Abstract

All articles of this category

Abstract

Pd(0)-catalyzed deprotection of allyl ethers using barbituric acid derivatives in protic polar solvent such as MeOH and aqueous 1,4-dioxane proceeds at room temperature without affecting a wide variety of functional groups. Control of the reaction temperature allows selective and successive cleavage of allyl, methallyl, and prenyl ethers. A study of ligand effects on the deprotection reveals that the improved reactivity in MeOH results from the accelerated oxidative addition to Pd(0).

Key words

barbituric acid - Pd(0)-catalyzed deprotection - allyl ethers - protic polar solvent - methallyl ethers - prenyl ethers

Full Text

References

References and Notes

1a Guibé F. Tetrahedron 1997, 53: 13509

1b Guibé F. Tetrahedron 1998, 54: 2967

2a Hutchins RO. Learn K. J. Org. Chem. 1982, 47: 4380

2b Honda M. Morita H. Nagakura I. J. Org. Chem. 1997, 62: 8932

2c Opatz T. Kunz H. Tetrahedron Lett. 2000, 41: 10185

2d Chandrasekhar S. Reddy CR. Rao RJ. Tetrahedron 2001, 57: 3435

2e Vutukuri DR. Bharathi P. Yu Z. Rajasekaran K. Tran M.-H. Thayumanavan S. J. Org. Chem. 2003, 68: 1146

2f Tsukamoto H. Kondo Y. Synlett 2003, 1061

2g Tsukamoto H. Suzuki T. Kondo Y. Synlett 2003, 1105

3a Kamal A. Laxman E. Rao NV. Tetrahedron Lett. 1999, 40: 371

3b Bartoli G. Cupone G. Dalpozzo R. De Nino A. Maiuolo L. Marcantoni E. Procopio A. Synlett 2001, 1897

3c Kitov PI. Bundle DR. Org. Lett. 2001, 3: 2835

3d Chen F.-E. Ling X.-H. He Y.-P. Peng X.-H. Synthesis 2001, 1772

3e Yang SG. Park MY. Kim YH. Synlett 2002, 492

3f Ohkubo M. Mochizuki S. Sano T. Kawaguchi Y. Okamoto S. Org. Lett. 2007, 9: 773

3g Bailey WF. England MD. Mealy MJ. Thongsornkleeb C. Teng L. Org. Lett. 2000, 2: 489

3h Taniguchi T. Ogasawara K. Angew. Chem. Int. Ed. 1998, 37: 1136

3i Dahlen A. Sundgren A. Lahmann M. Oscarson S. Hilmersson C. Org. Lett. 2003, 5: 4085

3j Thomas RM. Mohan GH. Iyengar DS. Tetrahedron Lett. 1997, 38: 4721

3k Chary KP. Mohan GH. Iyengar DS. Chem. Lett. 1999, 28: 1223

3l RajaRam S. Chary KP. Salahuddin S. Iyengar DS. Synth. Commun. 2002, 30: 133

3m Tanaka S. Saburi H. Ishibashi Y. Kitamura M. Org. Lett. 2004, 6: 1873

3n Tanaka S. Saburi H. Kitamura M. Adv. Synth. Catal. 2006, 348: 375

3o Murakami H. Minami T. Ozawa F. J. Org. Chem. 2004, 69: 4482

4a Bartnicka H. Bojanowska I. Kalinowski MK. Aust. J. Chem. 1991, 44: 1077

4b Headly AD. Starnes SD. Wilson LY. Famini GR. J. Org. Chem. 1994, 59: 8040

4c Mollin J. Pavelek Z. Navrátilová J. Recmanová A. Coll. Czech. Chem. Commun. 1985, 50: 2670

5 In this time, the deallylation of 2a in THF proceeded even at room temperature, but required 24 hours for its completion (Table 1, entry 6). Use of Pd(PPh₃)₄ prepared according to the following literature procedure instead of commercially available one might improve the reactivity: Coulson DR. Inorg. Synth. 1972, 13: 121

6

Representative Procedure for Deprotection of Allyl Ether: To a test tube containing 2a (0.13 mmol), 1a (0.27 mmol), and Pd(PPh₃)₄ (7 µmol) was added MeOH (0.4 mL) under argon. The resulting mixture was sealed with a screw cap and agitated at r.t. for 1 h. The mixture was partitioned between EtOAc and sat. aq Na₂CO₃ and the aqueous layer was extracted with EtOAc (2 ×). The combined organic layers were washed with brine, dried over MgSO₄, and concentrated in vacuo. The residue was purified by silica gel chromatography to yield the deallylated product 3a.

7a Jursic BS. Neumann DM. Tetrahedron Lett. 2001, 42: 4103

7b Jursic BS. Stevens ED. Tetrahedron Lett. 2003, 44: 2203

For sulfone-catalyzed selective and successive cleavage of prenyl and methallyl ethers in the presence of allyl ethers, see:

8a Markovic D. Vogel P. Org. Lett. 2004, 6: 2693

8b Markovic D. Steunenberg P. Ekstrand M. Vogel P. Chem. Commun. 2004, 2444

For cleavage of prenyl ethers in the presence of allyl ethers, see:

9a Sharma GVM. Ilangovan A. Mahalingam AK. J. Org. Chem. 1998, 63: 9103

9b Sharma GVM. Reddy CG. Krishna PR. Synlett 2003, 1728

9c Tsuritani T. Shinokubo H. Oshima K. Tetrahedron Lett. 1999, 40: 8121

9d Vatéle J.-M. Synlett 2001, 1989

9e Vatéle J.-M. Synlett 2002, 507

9f Vatéle J.-M. Tetrahedron 2002, 58: 5689

9g Babu KS. Raju BC. Srinivas PV. Rao JM. Tetrahedron Lett. 2003, 44: 2525

9h Babu KS. Raju BC. Srinivas PV. Rao AS. Kumar SP. Rao JM. Chem. Lett. 2003, 32: 704

10

Characterization data for compounds 9-14.
4-Methoxyphenyl 3-O-Allyl-4-O-benzyl-2-O-methallyl-6-O-prenyl-β-d-galactopyranoside (9): ¹H NMR (400 MHz, CDCl₃): δ = 7.25-7.40 (m, 5 H), 6.99 (d, J = 8.8 Hz, 2 H), 6.78 (d, J = 8.8 Hz, 2 H), 5.93 (ddt, J = 5.6, 10.4, 17.2 Hz, 1 H), 5.33 (d, J = 17.2 Hz, 1 H), 5.27 (t, J = 6.8 Hz, 1 H), 5.18 (d, J = 10.4 Hz, 1 H), 5.01 (s, 1 H), 4.96 (d, J = 11.6 Hz, 1 H), 4.87 (s, 1 H), 4.77 (d, J = 7.6 Hz, 1 H), 4.67 (d, J = 11.6 Hz, 1 H), 4.33 (d, J = 12.0 Hz, 1 H), 4.23 (d, J = 12.0 Hz, 1 H), 4.19 (d, J = 5.6 Hz, 2 H), 3.82-3.95 (m, 4 H), 3.75 (s, 3 H), 3.51-3.61 (m, 3 H), 3.44 (dd, J = 2.8, 9.6 Hz, 1 H), 1.78 (s, 3 H), 1.72 (s, 3 H), 1.62 (s, 3 H). ¹³C NMR (100 MHz, C₆D₆): δ = 155.8, 152.4, 143.3, 139.6, 136.2, 135.7, 128.5, 128.1, 127.6, 122.0, 119.2, 116.0, 114.9, 111.7, 103.9, 82.5, 79.3, 77.1, 75.2, 74.5, 74.0, 71.9, 68.5, 68.0, 55.2, 25.8, 19.9, 18.0. IR (neat): 2914, 2875, 1507, 1233, 1102, 1054, 1027, 822, 746 cm^-1. MS (FAB): m/z = 538 [M]⁺. HRMS (FAB): m/z [M]⁺ calcd for C₃₂H₄₂O₇: 538.2928; found: 538.2916.
4-Methoxyphenyl 4-O-Benzyl-2-O-methallyl-6-O-prenyl-β-d-galactopyranoside (10): ¹H NMR (600 MHz, CDCl₃): δ = 7.39 (d, J = 7.2 Hz, 2 H), 7.35 (dd, J = 7.2, 7.2 Hz, 2 H), 7.30 (t, J = 7.2 Hz, 1 H), 6.99 (d, J = 9.0 Hz, 2 H), 6.80 (d, J = 9.0 Hz, 2 H), 5.29 (t, J = 6.3 Hz, 1 H), 5.01 (s, 1 H), 4.89 (s, 1 H), 4.85 (d, J = 11.7 Hz, 1 H), 4.77 (d, J = 7.2 Hz, 1 H), 4.75 (d, J = 11.7 Hz, 1 H), 4.40 (d, J = 12.0 Hz, 1 H), 4.18 (d, J = 12.0 Hz, 1 H), 3.96 (dd, J = 7.2, 11.4 Hz, 1 H), 3.88-3.92 (m, 2 H), 3.76 (s, 3 H), 3.68-3.71 (m, 3 H), 3.56-3.63 (m, 2 H), 2.39-2.43 (br s, 1 H), 1.77 (s, 3 H), 1.72 (s, 3 H), 1.63 (s, 3 H). ¹³C NMR (150 MHz, CDCl₃): δ = 155.2, 151.5, 142.4, 138.5, 137.5, 128.4, 128.1, 127.8, 120.7, 118.3, 114.5, 112.5, 102.8, 79.6, 76.7, 75.5, 75.1, 74.1, 73.9, 68.2, 67.8, 55.6, 25.8, 19.7, 18.0. IR (neat): 3300-3600 (br), 2914, 2865, 1507, 1453, 1378, 1214, 1061, 826, 747 cm^-1. MS (EI): m/z (%) = 498 [M]⁺ (0.45), 430 (0.36), 374 (1.9), 307 (5.6), 262 (2.6), 214 (5.3), 192 (15), 145 (15), 124 (100), 91 (94). HRMS (EI): m/z [M]⁺ calcd for C₂₉H₃₈O₇: 498.2615; found: 498.2616.
4-Methoxyphenyl 3-O-Benzoyl-4-O-benzyl-2-O-methallyl-6-O-prenyl-β-d-galactopyranoside (11): ¹H NMR (400 MHz, CDCl₃): δ = 8.04 (dd, J = 1.2, 8.0 Hz, 2 H), 7.56 (tt, J = 1.2, 8.0 Hz, 1 H), 7.43 (dd, J = 8.0, 8.0 Hz, 2 H), 7.20-7.30 (m, 5 H), 7.03 (d, J = 9.2 Hz, 2 H), 6.81 (d, J = 9.2 Hz, 2 H), 5.24 (t, J = 6.8 Hz, 1 H), 5.24 (dd, J = 3.4, 10.2 Hz, 1 H), 4.92 (d, J = 7.6 Hz, 1 H), 4.89 (s, 1 H), 4.76 (s, 1 H), 4.72 (d, J = 11.8 Hz, 1 H), 4.58 (d, J = 11.8 Hz, 1 H), 4.31 (d, J = 11.6 Hz, 1 H), 4.13 (dd, J = <1.0, 3.4 Hz, 1 H), 4.12 (d, J = 11.6 Hz, 1 H), 4.08 (dd, J = 7.6, 10.2 Hz, 1 H), 3.95 (dd, J = 6.8, 11.4 Hz, 1 H), 3.88 (dd, J = 6.8, 11.4 Hz, 1 H), 3.82 (ddd, J = <1.0, 6.8, 6.8 Hz, 1 H), 3.76 (s, 3 H), 3.56-3.64 (m, 2 H), 1.72 (s, 3 H), 1.62 (s, 3 H), 1.58 (s, 3 H). ¹³C NMR (100 MHz, CDCl₃): δ = 165.6, 155.1, 151.4, 142.1, 137.9, 137.2, 133.1, 129.7, 129.7, 128.3, 128.1, 127.9, 127.5, 120.7, 118.4, 114.4, 112.6, 103.0, 77.0, 76.8, 75.7, 75.0, 74.3, 73.5, 67.9, 67.8, 55.6, 25.8, 19.6, 18.1. IR (neat): 2931, 2867, 1719, 1507, 1451, 1270, 1216, 1067, 903, 826, 749, 710 cm^-1. MS (EI): m/z (%) = 602 [M]⁺ (1.3), 479 (8.7), 411 (21), 393 (5.7), 339 (6.2), 303 (4.6), 249 (20), 214 (15), 192 (18), 149 (22), 91 (100). HRMS (EI): m/z [M]⁺ calcd for C₃₆H₄₂O₈: 602.2877; found: 602.2867.
4-Methoxyphenyl 3-O-Benzoyl-4-O-benzyl-6-O-prenyl-β-d-galactopyranoside (12): ¹H NMR (400 MHz, CDCl₃): δ = 8.05 (dd, J = 1.2, 8.0 Hz, 2 H), 7.56 (tt, J = 1.2, 8.0 Hz, 1 H), 7.42 (dd, J = 8.0, 8.0 Hz, 1 H), 7.20-7.30 (m, 5 H), 7.03 (d, J = 9.2 Hz, 2 H), 6.80 (d, J = 9.2 Hz, 2 H), 5.28 (t, J = 6.8 Hz, 1 H), 5.22 (dd, J = 3.2, 10.4 Hz, 1 H), 4.86 (d, J = 8.0 Hz, 1 H), 4.73 (d, J = 11.6 Hz, 1 H), 4.59 (d, J = 11.6 Hz, 1 H), 4.35 (dd, J = 8.0, 10.4 Hz, 1 H), 4.15 (dd, J = <1.0, 3.2 Hz, 1 H), 3.96 (dd, J = 7.2, 11.6 Hz, 1 H), 3.88 (dd, J = 7.2, 11.6 Hz, 1 H), 3.85 (ddd, J = <1.0, 7.2, 7.2 Hz, 1 H), 3.76 (s, 3 H), 3.56-3.65 (m, 2 H), 2.49-2.55 (br s, 1 H), 1.72 (s, 3 H), 1.62 (s, 3 H). ¹³C NMR (100 MHz, CDCl₃): δ = 166.0, 155.3, 151.1, 137.9, 137.3, 133.2, 129.8, 129.5, 128.4, 128.1, 127.8, 127.6, 120.6, 118.5, 114.4, 102.6, 75.8, 75.1, 74.2, 73.8, 69.7, 67.8, 67.8, 55.6, 25.8, 18.1. IR (neat): 3250-3600(br), 2912, 2836, 1717, 1507, 1451, 1273, 1216, 1065, 1027, 827, 748, 712 cm^-1. MS (EI): m/z (%) = 548 [M]⁺ (0.34), 425 (8.5), 357 (34), 249 (4.0), 214 (11), 192 (13), 124 (100), 91 (97). HRMS (EI): m/z [M]⁺ calcd for C₃₂H₃₆O₈: 548.2410; found: 548.2411.
4-Methoxyphenyl 2-O-Acetyl-3-O-benzoyl-4-O-benzyl-6-O-prenyl-β-d-galactopyranoside (13): ¹H NMR (400 MHz, CDCl₃): δ = 8.01 (d, J = 7.8 Hz, 2 H), 7.57 (t, J = 7.8 Hz, 1 H), 7.43 (dd, J = 7.8, 7.8 Hz, 2 H), 7.16-7.28 (m, 5 H), 6.98 (d, J = 9.0 Hz, 2 H), 6.80 (d, J = 9.0 Hz, 2 H), 5.79 (dd, J = 7.6, 10.4 Hz, 1 H), 5.29 (t, J = 6.8 Hz, 1 H), 5.21 (dd, J = 3.2, 10.4 Hz, 1 H), 4.98 (d, J = 7.6 Hz, 1 H), 4.71 (d, J = 11.6 Hz, 1 H), 4.56 (d, J = 11.6 Hz, 1 H), 4.20 (dd, J = <1.0, 3.2 Hz, 1 H), 3.96 (dd, J = 7.2, 11.6 Hz, 1 H), 3.89 (dd, J = 7.2, 11.6 Hz, 1 H), 3.87 (ddd, J = 1.0, 7.2, 7.2 Hz, 1 H), 3.76 (s, 3 H), 3.58-3.66 (m, 2 H), 1.98 (s, 3 H), 1.72 (s, 3 H), 1.63 (s, 3 H). ¹³C NMR (100 MHz, CDCl₃): δ = 169.3, 165.7, 155.3, 151.2, 137.7, 137.3, 133.4, 129.8, 129.0, 128.5, 128.1, 127.9, 127.5, 120.6, 118.5, 114.4, 100.8, 75.0, 74.5, 73.8, 73.8, 69.5, 67.8, 67.7, 55.6, 25.8, 20.8, 18.0. IR (neat): 2935, 2869, 1752, 1719, 1507, 1272, 1212, 1067, 1027, 828, 749, 714 cm^-1. MS (EI): m/z (%) = 590 [M]⁺ (0.26), 467 (3.7), 399 (54), 339 (5.0), 277 (30), 249 (27), 175 (8.5), 124 (30), 91 (100). HRMS (EI): m/z [M]⁺ calcd for C₃₄H₃₈O₉: 590.2516; found: 590.2518.
4-Methoxyphenyl 2-O-Acetyl-3-O-benzoyl-4-O-benzyl-β-d-galactopyranoside (14): ¹H NMR (400 MHz, CDCl₃): δ = 8.05 (dd, J = 1.2, 8.0 Hz, 2 H), 7.60 (tt, J = 1.2, 8.0 Hz, 1 H), 7.47 (dd, J = 8.0, 8.0 Hz, 2 H), 7.23-7.26 (m, 5 H), 6.96 (d, J = 9.2 Hz, 2 H), 6.81 (d, J = 9.2 Hz, 2 H), 5.81 (dd, J = 8.0, 10.4 Hz, 1 H), 5.22 (dd, J = 2.8, 10.4 Hz, 1 H), 5.01 (d, J = 8.0 Hz, 1 H), 4.76 (d, J = 11.6 Hz, 1 H), 4.48 (d, J = 11.6 Hz, 1 H), 4.13 (dd, J = <1.0, 2.8 Hz, 1 H), 3.84-3.90 (m, 1 H), 3.73-3.78 (m, 4 H), 3.55-3.62 (m, 1 H), 2.00 (s, 3 H), 1.58-1.65 (br s, 1 H). ¹³C NMR (100 MHz, CDCl₃): δ = 169.4, 165.8, 155.3, 151.0, 137.1, 133.6, 129.8, 128.9, 128.6, 128.4, 128.3, 128.0, 118.3, 114.5, 100.5, 75.2, 72.7, 74.6, 73.1, 69.4, 61.6, 55.6, 20.8. IR (neat): 3350-3600 (br), 2935, 2883, 1752, 1719, 1507, 1272, 1212, 1069, 1027, 828, 749, 698 cm^-1. MS (EI): m/z (%) = 522 [M]⁺ (0.35), 399 (22), 339 (3.0), 277 (9.5), 249 (18), 217 (3.5), 175 (8.5), 124 (25), 91 (100). HRMS (EI): m/z [M]⁺ calcd for C₂₉H₃₀O₉: 522.189; found: 522.1868.

11a Wunberg T. Kallus C. Opatz T. Henke S. Schmidt W. Kunz H. Angew. Chem. Int. Ed. 1998, 37: 2503

11b Kallus C. Opatz T. Wunberg T. Schmidt W. Henke S. Kunz H. Tetrahedron Lett. 1999, 40: 7783

12 Frost CG. Howarth J. Williams JMJ. Tetrahedron: Asymmetry 1992, 3: 1089

13a Sakaki S. Nishikawa M. Ohyoshi A. J. Am. Chem. Soc. 1980, 102: 4062

13b Åkermark B. Zetterberg K. Hansson S. Krakenberger B. Vitagliano A.
J. Organomet. Chem. 1987, 335: 133

13c Åkermark B. Krakenberger B. Hansson S. Vitagliano A. Organometallics 1987, 6: 620

13d Szabó KJ. Organometallics 1996, 15: 1128

13e Szabó KJ. J. Am. Chem. Soc. 1996, 118: 7818

13f Ross J. Chen W. Xu L. Xiao J. Organometallics 2001, 20: 138

For Pd(0)-catalyzed direct allylation of 1,3-dicarbonyl compounds with allyl alcohols in aqueous media, see:

14a Manabe K. Kobayashi S. Org. Lett. 2003, 5: 3241

14b Kinoshita H. Shiokubo H. Oshima K. Org. Lett. 2004, 6: 4085

14c Kinoshita H. Shiokubo H. Oshima K. Angew. Chem. Int. Ed. 2005, 44: 2097

For Pd(0)-catalyzed direct allylation of 1,3-dicarbonyl compounds with allylic alcohols in nonaqueous media, see:

15a Tamaru Y. Horino Y. Araki M. Tanaka S. Kimura M. Tetrahedron Lett. 2000, 41: 5705

15b Kimura M. Mukai R. Tanigawa N. Tanaka S. Tamaru Y. Tetrahedron 2003, 59: 7767

15c Ozawa F. Okamoto H. Kawagishi S. Yamamoto S. Minami T. Yoshifuji M. J. Am. Chem. Soc. 2002, 124: 10968

15d Ozawa F. Ishiyama T. Yamamoto S. Kawagishi S. Murakami H. Yoshifuji M. Organometallics 2004, 23: 1698

15e Kayaki Y. Koda T. Ikariya T. J. Org. Chem. 2004, 69: 4989

15f Hou R.-S. Wang H.-M. Huang H.-Y. Chen L.-C. Heterocycles 2005, 65: 1917

15g Patil NT. Yamamoto Y. Tetrahedron Lett. 2004, 45: 3101

15h Yang S.-C. Hsu Y.-C. Gan K.-H. Tetrahedron 2006, 62: 3949

The following reports also suggested that alcoholic solvents would promote the oxidative addition to Pd(0) catalyst:

16a Tsukamoto H. Suzuki R. Kondo Y. J. Comb. Chem. 2006, 8: 289

16b Yokogi M. Kuwano R. Tetrahedron Lett. 2007, 48: 6109

17

There are a few reports on carboxylic acids promoted Tsuji-Trost reaction.^14a,15g,h In our systems, barbituric acids play dual roles as acids and nucleophiles.

18

Less acidic acyclic 1,3-dicarbonyl compounds did not scavenge the allyl group of 2a in aqueous 1,4-dioxane at room temperature. This result is quite different from the aqueous biphasic Tsuji-Trost reaction developed by Shinokubo and Oshima.^14b Our system does not require biphasic systems, water-soluble TPPTS [trisodium salt of tri(m-sulfophenyl)phosphine] as a ligand, and additional base.